Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AYLA Ayala Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
BEAM Beam Therapeutics Inc.	$1.86B	$0 0.0% of portfolio	0	Q3 2024 New
BGNE Bei Gene, Ltd.	$18.7B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
BLTE Belite Bio, Inc	$1.37B	$0 0.0% of portfolio	0	Q3 2024 New
BYSI Beyond Spring Inc.	$64.2M	$0 0.0% of portfolio	0	Q3 2024 New
BCYC Bicycle Therapeutics PLC	$395M	$0 0.0% of portfolio	0	Q3 2024 New
BCAB Bio Atla, Inc.	$19.2M	$0 0.0% of portfolio	0	Q3 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.43B	$0 0.0% of portfolio	0	Q3 2024 New
BLRX Bio Line Rx Ltd.	$8.61M	$0 0.0% of portfolio	0	Q3 2024 New
BMEA Biomea Fusion, Inc.	$117M	$0 0.0% of portfolio	0	Q3 2024 New
BNOX Bionomics Limited	$24.1M	$0 0.0% of portfolio	0	Q3 2024 New
BNTX Bio N Tech Se	$29.8B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
BPTS Biophytis Sa	$115M	$0 0.0% of portfolio	0	Q3 2024 New
BRTX Bio Restorative Therapies, Inc.	$5.95M	$0 0.0% of portfolio	0	Q3 2024 New
BTAI Bio Xcel Therapeutics, Inc.	$10.6M	$0 0.0% of portfolio	0	Q3 2024 New
BDTX Black Diamond Therapeutics, Inc.	$70.1M	$0 0.0% of portfolio	0	Q3 2024 New
BLUE Bluebird Bio, Inc.	$652M	$0 0.0% of portfolio	0	Q3 2024 New
BPMC Blueprint Medicines Corp	$5.22B	$0 0.0% of portfolio	0	Q3 2024 New
BOLT Bolt Biotherapeutics, Inc.	$21.1M	$0 0.0% of portfolio	0	Q3 2024 New
BCLI Brainstorm Cell Therapeutics Inc.	$73.7M	$0 0.0% of portfolio	0	Q3 2024 New
BBIO Bridge Bio Pharma, Inc.	$4.31B	$0 0.0% of portfolio	0	Q3 2024 New
CCCC C4 Therapeutics, Inc.	$180M	$0 0.0% of portfolio	0	Q3 2024 New
CABA Cabaletta Bio, Inc.	$62.4M	$0 0.0% of portfolio	0	Q3 2024 New
CANF Can Fite Bio Pharma Ltd.	$44.1M	$0 0.0% of portfolio	0	Q3 2024 New
CADL Candel Therapeutics, Inc.	$236M	$0 0.0% of portfolio	0	Q3 2024 New
CAPR Capricor Therapeutics, Inc.	$321M	$0 0.0% of portfolio	0	Q3 2024 New
CARA Cara Therapeutics, Inc.	$255M	$0 0.0% of portfolio	100	Q4 2019 New
CRDF Cardiff Oncology, Inc.	$156M	$0 0.0% of portfolio	0	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$99.8M	$0 0.0% of portfolio	0	Q3 2024 New
CASI Casi Pharmaceuticals, Inc.	$35.5M	$0 0.0% of portfolio	0	Q3 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.25B	$0 0.0% of portfolio	0	Q3 2024 New
CVM Cel Sci Corp	$18.6M	$0 0.0% of portfolio	0	Q3 2024 New
CELC Celcuity Inc.	$178M	$0 0.0% of portfolio	0	Q3 2024 New
CLDX Celldex Therapeutics, Inc.	$1.14B	$0 0.0% of portfolio	0	Q3 2024 New
CLLS Cellectis S.A.	$84.2M	$0 0.0% of portfolio	0	Q3 2024 New
CELUW Celularity Inc Wt Exp 05/24/20	$0	$0 0.0% of portfolio	0	Q3 2024 New
CNTA Centessa Pharmaceuticals PLC	$1.48B	$0 0.0% of portfolio	0	Q3 2024 New
IPSC Century Therapeutics, Inc.	$58.3M	$0 0.0% of portfolio	0	Q3 2024 New
CSBR Champions Oncology, Inc.	$128M	$0 0.0% of portfolio	0	Q3 2024 New
CMMB Chemomab Therapeutics Ltd.	$24.2M	$0 0.0% of portfolio	0	Q3 2024 New
CMRX Chimerix Inc	$285M	$0 0.0% of portfolio	0	Q3 2024 New
CDXC Chroma Dex Corp.	$360M	$0 0.0% of portfolio	0	Q3 2024 New
CINC Cin Cor Pharma, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
CTXR Citius Pharmaceuticals, Inc.	$530M	$0 0.0% of portfolio	0	Q3 2024 New
CLSD Clearside Biomedical, Inc.	$59M	$0 0.0% of portfolio	0	Q3 2024 New
CDXS Codexis, Inc.	$288M	$0 0.0% of portfolio	0	Q3 2024 New
COGT Cogent Biosciences, Inc.	$516M	$0 0.0% of portfolio	0	Q3 2024 New
CGTX Cognition Therapeutics Inc	$17.5M	$0 0.0% of portfolio	0	Q3 2024 New
CHRS Coherus Bio Sciences, Inc.	$114M	$0 0.0% of portfolio	0	Q3 2024 New
CLGN Coll Plant Biotechnologies LTD	$46.6M	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.